Axios reported Tuesday that Eli Lilly is overtaking Novo Nordisk, with Zepbound projected to hit $18 billion in sales next year versus Wegovys $16.5 billion
None of them were depressed, but each was saying things like, Well, whats the point? Maybe I dont even care about that job promotion. I dont know what it is, but Im not even excited to go out with my friends. And these three in particular had been on GLP-1s
Combination therapy also showed lower risks for all-cause hospitalization (HR, 0.86
It supports your journey in managing body mass and improving health indicators related to obesity, like blood sugar levels and insulin sensitivity
Glutathione transdermal gel, beyond its traditional indications, may offer a variety of other therapeutic uses due to its antioxidant properties
If glycine inclusion increases cost significantly, it is probably not worth the premium given the limited evidence for meaningful benefit at the doses used